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SRp40Inﬂuenza A virus encodes two segments (7 and 8) that producemRNAs that can be spliced.Wehave investigated
if naturally occurring sequence polymorphisms in the inﬂuenza A virus family affects splicing of these viral
mRNAs, as that could potentially alter the NS1/NS2- and/or M1/M2-protein ratios. We compared splicing
efﬁciency of segment 7 and 8 mRNAs of A/Brevig Mission/1918/1 (H1N1) and A/Netherlands/178/95
(H3N2), as well as various H5N1 avian strains. Results revealed that both segment 7 and 8 mRNAs of
A/Brevig Mission/1918/1 (H1N1) were inefﬁciently spliced compared to other inﬂuenza virus segment 7 and
8mRNAs. This resulted in production of higher levels of functional NS1 protein, which could potentially contribute
to the pathogenic properties of the A/BrevigMission/1918/1 (H1N1). We also show that A/Brevig Mission/1918/1
(H1N1) segment 8 mRNAs responded differently to overexpression of SR proteins than A/Netherlands/178/95
(H3N2).
© 2011 Elsevier Inc. All rights reserved.Introduction
Properties that determine the pathogenicity of inﬂuenza viruses are
ofmajor interest (deWit and Fouchier, 2008). In general, it appears that
the ability of an inﬂuenza virus subtype to replicate to high levels in its
host, to cause infection also in the lower respiratory tract including alveoli,
to induce high cytokine production, as well as antagonising innate
immune responses correlate with high virulence (Basler and Aguilar,
2008). While mutations in the polymerase genes appear to confer
high replicative capacity and sequence variation in the HA and NA
open reading frames affect viral tropism, the NS1 protein antagonises
the innate immune response to the viral infection, more speciﬁcally
the interferon response (Basler andAguilar, 2008). Although the primary
protein sequence determines the pathogenic properties of these viruses,
the expression levels of NS1 protein could potentially also affect they Medicine, Section of Medical
14c, 221 84 Lund, Sweden.
artz).
rights reserved.ability of a particular inﬂuenza virus subtype to cope with the innate
immune response during the infection of the host.
Inﬂuenza viruses replicate in the nucleus of the infected cell
(Palese and Shaw, 2006). There, the eight RNA segments of the viral
genome are transcribed into mRNAs encoding at least one viral pro-
tein each. Two of the segments, segments 7 and 8, give rise to at
least two protein products each, one of which is produced from the
unspliced mRNA transcribed directly off the viral RNA segment, and
one that is produced from a spliced mRNA generated from the same
viral RNA segment. Segment 7 encodes M1 from the unspliced
mRNA and M2 from the spliced mRNA, while segment 8 encodes
NS1 from the unspliced mRNA and NS2 from the spliced mRNA. The
ratio between unspliced versus spliced mRNAs may determine the
relative concentrations of the NS1 to NS2 protein andM1 to M2 protein
that are synthesised in the infected cell. Splicing efﬁciency of these
mRNAs may therefore affect the replication and pathogenesis of the
inﬂuenza A virus. In particular the NS1 protein has been implicated
in the pathogenesis of inﬂuenza virus (Billharz et al., 2009).
Splicing efﬁciency of the inﬂuenza virus segments changes during
the course of the viral infection and splicing is affected by both viral
and cellular proteins (Valcarcel et al., 1991). The inﬂuenza virus NS1
protein has been shown to affect splicing and transport of mRNAs
(Fortes et al., 1994; Garaigorta and Ortin, 2007; Lu et al., 1994; Muraki
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of the NS1 protein point to an important role of this protein in the
regulation of viral and cellular RNA processing, e.g., NS1 binds RNA
directly (Hatada et al., 1992), it affects the subcellular localisation
of splicing factors (Fortes et al., 1995), it inhibits polyadenylation by
interacting with the canonical polyadenylation factor CPSF-30
(Nemeroff et al., 1998), and it inhibits translation (Aragon et al.,
2000). The cellular splicing factor ASF/SF2 has been shown to regulate
inﬂuenza virus RNA splicing (Shih and Krug, 1996). Moreover, knock-
down of CLK1, a cellular kinase that phosphorylates ASF/SF2, by siRNA,
or inhibition of CLK1 with TG003, strongly reduced viral replication
(Karlas et al., 2010). Splicing efﬁciency of cellular mRNAs is regulated
by cis-acting RNA elements termed splicing enhancers and splicing
silencers that interact with cellular factors (Blencowe, 2000; Cartegni
et al., 2002). RNA sequences on inﬂuenza virus mRNAs exert a
cis-acting effect on inﬂuenza virus mRNA splicing (Nemeroff et al.,
1992). The intracellular concentrations of RNA-binding proteins,
the number of RNA elements, or binding sites for cellular factors at
each splice site, and the afﬁnity of each factor for a particular
RNA element will determine the outcome of the splicing reaction.
The enhancer and silencer RNA elements are not well conserved
and their existence on various mRNA is difﬁcult to predict due to
the large sequence heterogeneity of these RNA elements. As RNA
viruses often evolve very quickly as a result of the error prone RNA
polymerase, it is reasonable to speculate that naturally occurring
sequence polymorphismwithin the inﬂuenza virus A pool of viruses
may affect the splicing efﬁciency of the inﬂuenza virus segment 7
and 8 mRNAs. Here we have monitored the splicing efﬁciency of
inﬂuenza virus segment 7 and 8 mRNAs derived from A/Brevig Mission/
1918/1 (H1N1) (Tumpey et al., 2005), A/Netherlands/178/95 (H3N2)
(Rimmelzwaan et al., 2007), A/Goose/Guangdong/1/96 (H5N1) (Xu et
al., 1999), and A/Hong Kong/483/97 (H5N1) (C, Centers for disease
control, prevention, 1997) viruses. Our results demonstrate that
inﬂuenza virus segment 7 and8mRNAs derived fromdifferent inﬂuenza
A viruses are spliced with different efﬁciency. Segment 7 and 8 mRNAs
produced from inﬂuenza virus A/Brevig Mission/1918/1 (H1N1) stood
out as being very inefﬁciently spliced, thereby producingmore unspliced
mRNA. We show that this results in a higher production of functional
NS1 protein from A/Brevig Mission/1918/1 (H1N1) RNAs. Consequently,
we speculate that differences in splicing efﬁciency may affect the viral
replication levels in the host and/or pathogenic properties of inﬂuenza
viruses.NS1
NS2
CMV SD54 SA527
A/Netherlands/178/95 (H3N2)
mRNAs:
A
pCNH3N2
ATG
NS1
NS2
CMV SD54 SA527
A/Brevig Mission/1/1918 (H1N1)pCNH1N1
ATG
Fig. 1. (A) Schematic representations of CMV-promoter-driven plasmids pCNH3N2 and
(Rimmelzwaan et al., 2007) and A/Brevig Mission/1918/1 (H1N1) (Tumpey et al., 2005),
(SD54) sites, 3′-splice sites (SA527), and the HPV-16 late polyA signal (pA) are indicated
cytoplasmic RNA extracted from HeLa cells transfected in duplicates with pCNH3N2 orResults
Poor splicing efﬁciency of inﬂuenza virus A/Brevig Mission/1918/1 (H1N1)
segment 8 mRNA
In order to investigate if the RNA sequence polymorphism among
inﬂuenza viruses could affect viral RNA processing, we investigated if
naturally occurring RNA sequence polymorphisms in segment
8 affected inﬂuenza virus RNA splicing efﬁciency. To this end, we
selected two inﬂuenza viruses with different pathogenic properties:
pandemic Spanish A/Brevig Mission/1918/1 (H1N1) (Tumpey et al.,
2005) and seasonal inﬂuenza virus A/Netherlands/178/95 (H3N2)
(Rimmelzwaan et al., 2007). The NS1 and NS2 coding regions of
these two strains are 89% identical at the RNA level. To test if segment
8 mRNA of A/Brevig Mission/1918/1 (H1N1) was spliced with different
efﬁciency than segment 8 mRNAs from A/Netherlands/178/95 (H3N2),
sequences from the common ATG to the stop codon of NS2 were
PCR-ampliﬁed and inserted into a CMV-promoter driven expression
plasmid named pCL0806 (Collier et al., 2002), thereby creating
plasmids pCNH1N1andpCNH3N2 (Fig. 1A), respectively. These plasmids
were transfected into HeLa cells and cytoplasmic RNA was extracted.
Northern blot analysis revealed striking differences in NS RNA levels as
well as in the splicing efﬁciency between these two viral sequences
(Fig. 1B). While H3N2 produced high mRNA levels that were pre-
dominantly spliced, the H1N1 mRNA levels were low and predomi-
nantly unspliced (Fig. 1B). Quantitation revealed that 92% of the H3N2
mRNAs were spliced, whereas only 41% of the H1N1 mRNAs were
spliced. These results suggested that the function of cis-acting, viral
RNA elements were affected by the sequence differences between the
two viruses.
To further support the observation that H1N1 segment 8 mRNAs
were inefﬁciently spliced compared to H3N2 segment 8 mRNAs, we
expressed segment 8 of both viruses in the RNA polymerase I-based
expression system (Neumann and Kawaoka, 2001; Neumann et al.,
2000). In this expression system, a negative segment 8 RNA is produced
by cellular RNApolymerase I in transfected cells, and the positivemRNA
strand is produced by the inﬂuenza virus polymerase expressed from
cotransfected plasmids. In this case, the polymerase geneswere derived
from inﬂuenza virus A/WSN/33 (H1N1) (Neumannand Kawaoka, 2001;
Neumannet al., 2000). Polyadenylated cytoplasmic RNA from293T cells
transiently transfected with plasmids encoding the NS segment from
A/Brevig Mission/1918/1 (H1N1) (pH1N1) or A/Netherlands/178/95pA
NS1
NS2
NS1
NS2
pC
NH
1N
1
pC
NH
3N
2
18S
B
pA
pCNH1N1 encoding the NS protein coding region of A/Netherlands/178/95 (H3N2)
respectively. NS1 and NS2 open reading frames are indicated. Positions of 5′-splice
. Structures of mRNAs produced by the plasmids are indicated. (B) Northern blot of
pCNH1N1. 18S ribosomal RNA is shown as a loading control.
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the results described above, differences in splicing efﬁciency were
observed. While pH1N1 primarily produced unspliced NS1 mRNA,
pH3N2 gave rise to high levels of spliced NS2 mRNAs in addition to
unspliced NS1 mRNA (Fig. 2B, left panel). The RNAs were also analysed
by RT-PCR with primers that detected both NS1 and NS2 mRNAs.
Similar results were obtained by the RT-PCR analysis (Fig. 2B, right
panel). Detection of the unspliced and spliced inﬂuenza virus mRNAs
in the transfected cells by Northern blotting or RT-PCR was totally
dependent on the transfection of the various expression plasmids as
these mRNAs were undetectable in untransfected cells (Fig. 2B).
These results supported the conclusion that naturally occurringNS1
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Fig. 2. (A) Schematic representations of RNA polymerase I-promoter-driven plasmids (Neu
inﬂuenza virus segment 8 RNAs of A/Netherlands/178/95 (H3N2) (Rimmelzwaan et al., 2007
ATG had been mutationally converted to TAG in the plasmids named pH3N2dns and pH1N1
3′-splice sites (SA527), and the RNA polymerase I promoter (Pol-I), and terminator signal (
panel) Northern blot of cytoplasmic, polyadenylated RNA extracted from 293T cells transfect
(−) RNA from untransfected cells was subjected to Northern blotting and analysed in paralle
control. (right panel) RT-PCR with primers All_NS_and All_NS-Rev on cDNA of cytoplasmic,
pH3N2, pH1N1 or pH5N1. GAPDH cDNAs were ampliﬁed from the same samples. PCR prod
was subjected to RT-PCR and analysed in parallel with RNA from cells transfected with pH
extracted from 293T cells transfected in duplicates with plasmids pH3N2 or pH1N1. 18S ribsequence variations in inﬂuenza virus segment 8 could affect the efﬁ-
ciency of segment 8 pre-mRNA splicing.
Analysis of segment 8 mRNA splicing may be complicated by pre-
viously described effects of the NS1 protein on RNA processing e.g.,
inhibition or activation of splicing (Fortes et al., 1994; Garaigorta and
Ortin, 2007; Hale et al., 2008; Lu et al., 1994; Muraki et al., 2010). We
converted the NS ATG to TAG in plasmids pH1N1 and pH3N2 to prevent
expression of the NS1 and NS2 proteins. This resulted in plasmids
pH1N1dns and pH3N2dns (Fig. 2A). Analysis of mRNA produced from
these plasmids revealed that H3N2 mRNAs were more efﬁciently
spliced thanH1N1mRNAs. ComparingmRNAs produced from plasmids
pH1N1 and pH3N2 with the mRNAs produced from the pH1N1dns andmRNAs:
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mann and Kawaoka, 2001; Neumann et al., 2000) encoding the wt antisense strand of
) (pH3N2) or A/Brevig Mission/1918/1 (H1N1) (Tumpey et al., 2005) (pH1N1). The NS
dns. NS1 and NS2 open reading frames are indicated. Positions of 5′-splice sites (SD54),
t) are indicated. Structures of mRNAs produced by the plasmids are indicated. (B) (left
ed in duplicates with plasmids pH3N2 or pH1N1 as described in Materials and methods.
l with RNA from cells transfected with pH1N1. 18S ribosomal RNA is shown as a loading
polyadenylated RNA extracted from 293T cells transfected in duplicates with plasmids
ucts representing NS1 or NS2 mRNAs are indicated. (−) RNA from untransfected cells
3N2. M, molecular size marker; (C) Northern blot of cytoplasmic, polyadenylated RNA
osomal RNA is shown as a loading control.
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observed (Fig. 2 C). Therefore, we concluded that splicing efﬁciency was
determined by cis-acting RNA elements in the H1N1 and H3N2 mRNAs
and not by NS proteins potentially produced in this expression system.
Differences in splicing efﬁciency among H5N1 inﬂuenza virus segment
8 mRNA
To investigate if there were differences in splicing efﬁciency of
segment 8 mRNAs derived from various avian H5N1 isolates, we
also expressed segment 8 from two H5N1 isolates from the same
CMV-promoter driven expression vector pCL0806 (Collier et al., 2002).
mRNA levels and splicing efﬁciency were monitored from plasmids
expressing inﬂuenza virus A/Goose/Guangdong/1/96 (H5N1) (Xu et
al., 1999) (plasmid pGsGd), or inﬂuenza virus A/Hong Kong/483/97
(H5N1) (C, Centers for disease control, prevention, 1997) (plasmid
pHn) (Fig. 3A). While A/Goose/Guangdong/1/96 (H5N1) is of avian
origin (Xu et al., 1999), A/Hong Kong/483/97 was isolated from a
human individual that had been infected with highly pathogenic avian
inﬂuenza virus (C, Centers for disease control, prevention, 1997).
Analysis of cytoplasmic RNA isolated from 293T cells transfected
with either pHn or pGsGd revealed that high levels of mRNAs were
produced from pHn, whereas low levels of mRNAs were expressed
from pGsGd (Fig. 3 C). The mRNAs produced from pGsGd were less
efﬁciently spliced than mRNAs produced from pHn. In addition, H5N1
segment 8 pre-mRNA derived from A/Hong Kong/483/97 was more
efﬁciently spliced than H1N1 segment 8 mRNAs in the RNA polymerase
I expression system (Fig. 2B, right panel). We concluded that differences
inmRNA levels and splicing efﬁciencieswere present also among various
H5N1 inﬂuenza A virus isolates.
We observed that a large number of nucleotide differences (8-
nucleotide positions) between pHn (A/Hong Kong/483/97) and
pGsGd (A/Goose/Guangdong/1/96) were located in a short region
(27 nucleotides) between the NS ATG and the GT-dinucleotide ofCMV pSD54 SA527
A/Goose/Guangdong/1/96 (H5N1)
mRNAs:
NS1
NS2
CMV pSD54 SA527
A/Hong Kong/483/97 (H5N1) 
A
Hn: atggattccaacacTGtGTcAA
GsGd: atggattccaacacGAtAAcCT
B
ATG
ATG
pGsGd
pHn
pGs
NS1
NS2
NS1
NS2
CMV pSD54 SA527ATG
Fig. 3. (A) Schematic representations of CMV-promoter-driven plasmids pGs, pHn and pGsG
1999) here named GsGd, and inﬂuenza virus A/Hong Kong/483/97 (H5N1) (C, Centers for di
Positions of 5′-splice sites (SD54), 3′-splice sites (SA527) and the HPV-16 late polyA sign
(B) Alignment of the sequence between the ATG and SD54 of A/Goose/Guangdong/1/96 (H5
control, prevention, 1997) (pHn) are displayed. Capitalised letters indicate sequence polym
with pHn, pGs or pGsGd. 18S ribosomal RNA is shown as a loading control. Percentage splithe 5′-splice site (SD54) (Fig. 3B). As these nucleotide differences
were positioned close to the major 5′-splice site of the NS segment,
we investigated if this sequence-heterogeneity affected splicing efﬁ-
ciency. A hybrid between pHn and pGsGd was generated in which
the 27-nucleotide sequence from pGsGd replaced the corresponding
sequence in the pHn plasmid, thereby creating pGs (Fig. 3A). Analysis
of several experiments of hybrid plasmid pGs in parallel with pHn and
pGsGd plasmid by Northern blotting, revealed that insertion of the 27
nucleotides from pGsGd into pHn resulted in an intermediate pheno-
type (see pGs, Fig. 3 C). These results further supported the conclusion
that natural sequence variation in inﬂuenza virus strains could affect
mRNA levels and splicing efﬁciency of inﬂuenza A virus segment
8-derived mRNAs.
Inefﬁcient splicing of A/Brevig Mission/1918/1 (H1N1) segment 8 mRNAs
yielded higher levels of functionally active NS1 protein
We wished to investigate if poor splicing of the A/Brevig Mission/
1918/1 (H1N1) derived segment 8 mRNAs gave rise to more NS1
protein than segment 8 mRNAs from H3N2/Netherlands/1995 as NS1
has been implicated in A/Brevig Mission/1918/1 (H1N1) pathogenesis
(Billharz et al., 2009). Western blot analysis failed to reproducibly
detect NS1 protein from both A/BrevigMission/1918/1 (pCNH1N1) and
H3N2/Netherlands/1995 (pCNH3N2), probably due to low expression
levels (not shown).We therefore developed amore sensitive, functional
assay for NS1 expression, which monitors the previously described
inhibitory effect of NS1 protein on polyadenylation (Nemeroff et
al., 1998). The pE5-Luc expression plasmid contains two HPV-16
polyA signals and is efﬁciently polyadenylated at the upstream
pAE, resulting in E5 mRNA (Fig. 4A). If polyadenylation is inhibited,
read-through into the luciferase gene occurs and luciferase is
expressed. To demonstrate that this assay detects functional NS1
protein, we ﬁrst cotransfected the pE5-Luc expression plasmid
(Fig. 4A) with CMV-driven inﬂuenza virus NS1 expression plasmidsA
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Fig. 4. (A) Schematic structures of HPV-16 E5/luciferase expression plasmid pE5luc. HPV-16 early polyA signal (pAE) and late polyA signal (pAL) are indicated. The luciferase orf
expressed from the full-length mRNA is preceded by the poliovirus 2A internal ribosome entry site (IRES). (B) Western blot detection of FLAG-tagged NS1 production and actin
from serially diluted pFNS1-H1N1 plasmid transfected in 293T cells, or from cells transfected with pFNS1-H1N1, pFNS1-H3N2, and pFNS1-H5N1. (C) Fold luciferase induction
from pE5luc transfected in 293T cells in the absence or presence of serially diluted inﬂuenza virus NS1 expression plasmid pFNS1-H1N1. (D) Fold luciferase induction from
pE5luc transfected into 293T cells in the absence or presence of 12.5 ng each of the three NS1 expression plasmids pFNS1-H1N1, pFNS1-H5N1, and pFNS1-H3N2, or the
three inﬂuenza virus segment 8 expression plasmids pCNH1N1, pCNH3N2, and pHn (H5N1). (E) Fold luciferase induction from pE5luc transfected in 293T cells in the absence
or presence of serially diluted inﬂuenza virus segment 8 expression plasmids pCNH1N1, pCNH3N2 and pHn (H5N1).
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protein, as detected byWestern blotting (Fig. 4B). Luciferase produc-
tion was induced in a dose dependent manner up to 12.5 ng of trans-
fected NS1 plasmid per 35 mm plate (Fig. 4 C). Analysis of the
luciferase levels from cells transfected with pE5Luc and the FLAG-
tagged NS1 expression plasmids revealed that A/Brevig Mission/
1918/1 (pFNS1-H1N1) enhanced luciferase expression 18-fold, A/
Netherlands/178/95 (pFNS1-H3N2) 17-fold, while A/Hong Kong/
483/97 (pFNS1-H5N1) type failed to inhibit polyadenylation and in-
duce luciferase expression (Fig. 4D). The failure of pFNS1-H5N1 to
enhance luciferase activity was expected, as it has previously been
shown not to interact with polyadenylation factor CPSF-30, and not to
inhibit polyadenylation (Nemeroff et al., 1998). Overexpression of
CPSF-30 in addition to NS1 protein, restored luciferase levels,conﬁrming an effect of NS1 on polyadenylation (data not shown).
We concluded that the polyadenylation assay was speciﬁc for
NS1-mediated inhibition of polyadenylation and that the ability of
NS1 from A/Brevig Mission/1918/1 (H1N1) and from A/Netherlands/
178/95 (H3N2) to inhibit polyadenylation was similar.
We next tested the ability to inhibit polyadenylation and induce
luciferase expression of plasmids that produced segment 8 mRNAs
that could be spliced. The results revealed that H3N2/Netherlands/
178/95 (pCNH3N2) induced luciferase ﬁve-fold, whereas A/Brevig
Mission/1918/1 (pCNH1N1) caused an 11-fold increase in luciferase
expression (Fig. 4D). This effect was seen over a range of concentrations
of transfected NS1 plasmids (Fig. 4E). Segment 8 of A/Hong Kong/483/
97 (pHn) failed to induce luciferase as expected (Fig. 4D).We concluded
that the poorly spliced segment 8 mRNAs from A/Brevig Mission/1918/
51E. Backström Winquist et al. / Virology 422 (2012) 46–581 (pCNH1N1) produced more NS1 protein than the more efﬁciently
spliced segment 8 mRNAs derived from A/Netherlands/178/95
(pCNH3N2).NS1
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Fig. 5. (A) Northern blot of cytoplasmic RNA extracted from HeLa cells transfected with
pGs (H5N1) in the absence or presence of plasmids expressing ASF/SF2, SRp30c, or
SRp40. 18S ribosomal RNA is shown as a loading control. (B) Northern blot of cytoplasmic
RNA extracted from HeLa cells transfected in duplicates with pGs (H5N1) in the absence
(lanes 1 and 2) or presence of plasmids expressing SRp30c (lanes 3–6) or SRp30cDRS
(lanes 7–10). Two concentrations each of SRp30c or SRp30cDRS expression plasmid
were used: 1 μg (lanes 3, 4, 7, 8) or 0.5 μg (lanes 5, 6, 9, 10). 18S ribosomal RNA is
shown as a loading control. (C–D) Northern blots of cytoplasmic RNA extracted from
HeLa cells transfectedwith pGs (H5N1), pCNH3N2or pCNH1N1 in the absenceor presence
of plasmids expressing SRp40 (C) or ASF/SF2 (D). 18S ribosomal RNA is shown as a loading
control.Differential effects of cellular SR proteins on inﬂuenza virus segment
8 mRNA splicing and appearance in the cytoplasm
As it has been shown previously that SR proteins are involved in
the regulation of inﬂuenza virus RNA splicing (Shih and Krug,
1996), we wished to investigate if SR proteins differently affected
splicing of the various inﬂuenza viruses analysed here. Plasmids
expressingASF/SF2, SRp30c andSRp40were cotransfectedwith plasmid
pGs that expresses H5N1 mRNAs. The levels of unspliced and spliced
mRNAs were monitored by Northern blotting of cytoplasmic RNA
extracted from transfected HeLa cells. Surprisingly, overexpression of
all three SR proteins individually inhibited splicing of the NS mRNAs
(Fig. 5A). In parallel experiments in the lab, we have shown that
SRp40 enhances HIV-1 tat mRNA splicing (Tranell et al., 2010), that
SRp55 inhibits HIV-1 vpr splicing (Tranell et al., 2010) and that
SRp30c enhances HPV-16L1 mRNA splicing (Somberg et al., 2011)
(data not shown). The inhibitory effect of these SR proteins on in-
ﬂuenza virus H5N1 segment 8 mRNA splicing was therefore
striking.
Overexpression of SRp40 and ASF/SF2 appeared to inhibit splicing
and to reduce the overall levels of inﬂuenza virus mRNAs. This is likely
an effect of less efﬁcient nuclear export of unspliced viral mRNAs. In
contrast, SRp30c increased the levels of unspliced inﬂuenza virus
mRNAs in the cytoplasm, suggesting that SRp30c might aid in nuclear
export of inﬂuenza virus mRNAs (Fig. 5A and B). As the function of SR
proteins in nuclear mRNA export requires an intact RS-domain
(Cazalla et al., 2002; Huang and Steitz, 2001), we investigated the
effect on the inﬂuenza virus mRNAs of a mutant SRp30c, named
SRp30cDRS, that lacks the RS-domain but contains intact RNA-binding
domains. The results revealed that similarly to wt SRp30c, SRp30cDRS
inhibited inﬂuenza virus mRNA splicing (Fig. 5B), but in contrast to
SRp30c, SRp30cDRS failed to induce high levels of inﬂuenza virus
mRNAs in the cytoplasm (Fig. 5B). These results suggested that
SRp30c may regulate inﬂuenza virus mRNA splicing as well as assisting
in further processing or transport of the unspliced inﬂuenza virus
mRNAs to the cytoplasm.
Next we investigated if H1N1 and H3N2 inﬂuenza viruses
responded in a similar manner to H5N1 to the overexpression of SR
proteins. We ﬁrst analysed the number of predicted ASF/SF2, SRp40,
SC35 and SRp55 binding sites in segments 7 and 8 of A/H3N2/
Netherlands/178/95 (H3N2), A/Brevig Mission/1918/1 (H1N1) and
A/Hong Kong/483/97 (H5N1) using the ESE-ﬁnder program (Cartegni
et al., 2003). While H3N2/Netherlands/178/95 (H3N2) stood out by
having fewer predicted ASF/SF2 sites in segment 7 than A/Brevig
Mission/1918/1 (H1N1) and A/Hong Kong/483/97 (H5N1), A/Hong
Kong/483/97 (H5N1) had more potential SRp40 sites than A/Brevig
Mission/1918/1 (H1N1) and A/H3N2/Netherlands/178/95 (H3N2) in
segment 8. However, differences in number of potential SR-protein
binding sites that correlated with splicing efﬁciency could not be
detected.
To experimentally investigate the effect of SR proteins on the
splicing of segment8,we overexpressedASF/SF2 or SRp40with segment
8 mRNAs from H5N1, H1N1 and H3N2. Results revealed that H5N1 and
H3N2 derived mRNAs responded to SR protein overexpression in a
similar manner, both produced less spliced mRNA and the levels of
mRNAaccumulatedwere lower. However, H1N1 appeared unresponsive
to ASF/SF2 and SRp40 (Fig. 5 C and D). Similar levels of unspliced H1N1
NS mRNAs were detected in the absence or presence of ASF/SF2 or
SRp40 (Fig. 5 C and D). We concluded that inefﬁcient splicing of H1N1
mRNAs could not be further inhibited by overexpression of the
SR proteins, suggesting that H1N1 mRNA splicing was under control
of other cellular factors, or that H1N1 mRNAs lack one or more RNA
elements that might be targeted by ASF/SF2 and SRp40. These results
further supported the conclusion that splicing of inﬂuenza virus
H1N1 mRNAs is differently regulated compared to splicing of H5N1
and H3N2 mRNAs.
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Fig. 6. (A) Schematic representations of CMV-promoter-driven plasmids pCMH3N2, pCMH5N1, and pCMH1N1 encoding the M protein coding region of A/Netherlands/178/95
(H3N2) (Rimmelzwaan et al., 2007), A/Hong Kong/483/97 (H5N1) (C, Centers for disease control, prevention, 1997), and A/Brevig Mission/1918/1 (H1N1) (Tumpey et al.,
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Structures of mRNAs produced by the plasmids are indicated. (B) Northern blot of cytoplasmic RNA extracted from HeLa cells transfected in duplicates with M-encoding pCMH3N2
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A/Brevig Mission/1918/1 (H1N1)
If poor splicing efﬁciency was an inherent property of A/Brevig
Mission/1918/1 (H1N1) mRNAs, segment 7 and 8 mRNAs should both
be poorly spliced. To test this we constructed CMV-driven segment 7
expression plasmids. To this end, we ﬁrst PCR ampliﬁed segment 7
from A/Brevig Mission/1918/1 (H1N1) (Reid et al., 2002; Tumpey et
al., 2005) and from A/Netherlands/178/95 (H3N2) (Rimmelzwaan et
al., 2007), from the common M1- and M2-ATG in the 5′-end of the
segment to the stop codon of M2 (Fig. 6A). The PCR products were
inserted into the CMV-driven pCL086 plasmid vector (Collier et al.,
2002), and the plasmids were named pCMH1N1 and pCMH3H2
(Fig. 6A). Northern blot analysis of cytoplasmic RNA extracted from
transfected HeLa cells revealed that also segment 7 derived from A/-
Brevig Mission/1918/1 (H1N1) produced little RNA, and that the RNA
was poorly spliced (Fig. 6B, lanes 7 and 8). In contrast, H3N2 segment
7 RNAs were highly expressed and were predominantly in the form
of spliced mRNA (Fig. 6B, lanes 5 and 6). These results were similar
to those obtained with segment 8 mRNAs (Fig. 6B, lanes 1–4). We con-
cluded that inefﬁcient splicing is an inherent property of mRNAs de-
rived from A/Brevig Mission/1918/1 (H1N1).
Segment 7 mRNAs derived from highly pathogenic avian ﬂu H5N1 are
more efﬁciently spliced than segment 7 mRNAs derived from A/Brevig
Mission/1918/1 (H1N1)
We also PCR ampliﬁed and subcloned segment 7 sequences derived
from the avian inﬂuenza virus A/Hong Kong/483/97 (H5N1) (C, Centers
for disease control, prevention, 1997), resulting in plasmid pCMH5N1
(Fig. 6A). This plasmid was transfected into 293T cells in parallel withpCMH1N1 and pCMH3N2 and cytoplasmic mRNA levels and splicing
efﬁciency of the inﬂuenza virus mRNAs were determined by Northern
blotting (Fig. 6C). The RNAs derived from A/Hong Kong/483/97
(pCMH5N1) were more efﬁciently spliced than RNAs derived from
A/Brevig Mission/1918/1 (pCMH1N1), but less efﬁciently spliced
than those from A/Netherlands/178/95 (pCMH3N2) (Fig. 6C). We
found that segment 7 mRNAs from all three inﬂuenza virus isolates
were spliced with different efﬁciency. Interestingly, mRNAs from
pCMH1N1 were the most poorly spliced mRNAs. Therefore, both
segment 7 and segment 8 mRNAs derived from A/Brevig Mission/
1918/1 (H1N1) are less efﬁciently spliced than mRNAs from all
other inﬂuenza viruses tested, further supporting the conclusion that
inefﬁcient splicing is an inherent property of A/Brevig Mission/1918/1
(H1N1).
Segment 7 mRNAs derived from the A/Brevig Mission/1918/1 (H1N1)
isolate are poorly spliced in both human and avian cells
If the A/Brevig Mission/1918/1 (H1N1) virus is derived from an
avian host, it might be better adapted to avian cells (Reid et al.,
2004), producing higher mRNA levels that are more efﬁciently spliced
in these cells than in human cells, perhaps displaying a phenotype
resemblingA/Netherlands/178/95 (H3N2) in human cells.We therefore
transfected the avianQT6 cell line, which originates from Japanese quail
(Lee et al., 2008; Moscovici et al., 1977), with plasmids expressing seg-
ment 7 mRNAs of A/Brevig Mission/1918/1 (pCMH1N1), A/Netherlands/
178/95 (pCMH3N2) or A/Hong Kong/483/97 (pCMH5N1). Analysis of cy-
toplasmic RNA extracted from these cells revealed that A/Netherlands/
178/95 (H3N2) segment 7 mRNAs were efﬁciently spliced, whereas A/
Brevig Mission/1918/1 (H1N1) segment 7 mRNAs were not (Fig. 7).
Like in HeLa cells and 293T cells, H5N1 displayed an intermediate
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Fig. 7. Northern blot on cytoplasmic RNA extracted from the avian quail cell line QT6
(Lee et al., 2008; Moscovici et al., 1977) transfected in with pCMH1N1, pCMH3N2 or
pCMH5N1, as described in Materials and methods. 28S ribosomal RNA is shown as a
loading control. Percentage spliced M mRNA in the blot was calculated as described
in Materials and methods.
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the A/Brevig Mission/1918/1 (H1N1) isolate are poorly spliced in both
human and avian cells.Retention of unspliced inﬂuenza virus mRNAs in the nucleus
As the A/BrevigMission/1918/1 (H1N1) derivedmRNAswere both
less abundant and less efﬁciently spliced than the A/Netherlands/178/
95 (H3N2) derived RNAs, we wished to determine if differences in
mRNA levels could be explained by subcellular mRNA distribution.
Fractionation of 293T cells transfected with pCMH1N1, pCMH3N2, or
pCMH5N1 followed by analysis of inﬂuenza virus mRNA levels in the
nuclear and in the cytoplasmic fractions compared to total inﬂuenza
virus RNA levels, revealed that high levels of H1N1 unspliced mRNAs
were trapped in the nucleus (Fig. 8). Analysis of total RNA from cells
transfected with plasmids expressing segment 8 mRNA yielded similar
results to those obtained with segment 7mRNAs (data not shown). The
low levels of cytoplasmic mRNAs produced by the inﬂuenza virus A/
Brevig Mission/1918/1 expression plasmid pCMH1N1 could therefore
be explained by the entrapment of the poorly spliced mRNAs in the
nucleus.pC
MH
1N
1
pC
MH
3N
2
pC
MH
5N
1
Total Cyto Nuclear
M1
M2
% spliced: 25 70 53 46 90 82 6 38 40
pC
MH
1N
1
pC
MH
3N
2
pC
MH
5N
1
pC
MH
1N
1
pC
MH
3N
2
pC
MH
5N
1
m
oc
k
m
oc
k
m
oc
k
GAPDH
Fig. 8. Northern blot on total cellular RNA, cytoplasmic RNA or nuclear RNA extracted
from 293T cells transfected with pCMH1N1, pCMH3N2, or pCMH5N1. RNA was
extracted as described in Materials and methods. Percentage spliced M mRNA in the
blot was calculated as described in Materials and methods. Blots were also probed
with radiolabelled DNA that detects GAPDH mRNA.RNA sequences causing differences in inﬂuenza virus segment 7 mRNA
splicing efﬁciency mapped to the intronic region
In order to investigate where in segment 7 the cis-acting determi-
nants of splicing were located, hybrids between segment 7 sequences
of A/Brevig Mission/1918/1 (H1N1) and A/Netherlands/178/95
(H3N2) were generated (Fig. 9A). The “A” of the M1/M2 ATG denotes
1 and the last nucleotide position of the M2 stop codon denotes 982
(Fig. 9A). Break points for the hybrids were introduced 250-, 425-,
622-, and 691-nucleotides downstream of the ATG (Fig. 9A). The
hybrids were transfected into HeLa cells, cytoplasmic RNA was
extracted and subjected toNorthern blotting (Fig. 9B). After quantitation
of the Northern blots, percentage splicing of the mRNAs was calculated
(Fig. 9A). Each mutant was analysed in three independent transfections
with similar results. The results revealed that hybrid p1213, with A/
Netherlands/178/95 (H3N2) sequences downstream of position 250,
was spliced as efﬁciently as the full length A/Netherlands/178/95
(H3N2) segment (Fig. 9A and B). Addition of more sequences from
A/Brevig Mission/1918/1 (H1N1), as in p1819 and p2223, caused
a reduction in splicing efﬁciency (Fig. 9A and C). The determinants
of efﬁcient splicing are therefore located between positions 250
and 982. The majority of those were located between positions 250
and 690, as hybrid p1011 was almost as poorly spliced as the full
A/Brevig Mission/1918/1 (H1N1), and hybrid p1415 displayed an
intermediate phenotype (Fig. 9A and B). Finally, hybrid p1617,
which contained A/Brevig Mission/1918/1 (H1N1) sequences from
251 to 982 was poorly spliced (Fig. 9B), conﬁrming that sequences
in the central region of A/Netherlands/178/95 (H3N2) enhanced
splicing. In conclusion, the more sequences that were derived from
the central region of A/Brevig Mission/1918/1 (H1N1) segment 7,
the lower the splicing efﬁciency was (Fig. 9 C). Furthermore, these
results strengthened the conclusion that differences in splicing efﬁcien-
cy between A/Brevig Mission/1918/1 (H1N1) and A/Netherlands/178/
95 (H3N2) were caused by sequence polymorphism that affected
cis-acting splicing regulatory elements.
Discussion
TheNS1 protein has been implicated in inﬂuenza virus pathogenesis
as it is an inhibitor of interferon synthesis at an early stage of the viral
infection (Hale et al., 2008). As such, NS1may pave theway for efﬁcient
replication and quick transmission of virus between cells at the initial
phase of the infection. Although it was shown that insertion of A/Brevig
Mission/1918/1 (H1N1) segment 8 in the background of another H1N1
virus attenuated the parental virus in mice (Basler et al., 2001), it has
also been shown that NS1 from A/Brevig Mission/1918/1 (H1N1) is an
efﬁcient inhibitor of interferon responses in human cells. One may
therefore speculate that inefﬁcient splicing of segment 8 mRNAs
would results in production of high levels of NS1 protein after infection
with A/Brevig Mission/1918/1 (H1N1), and that these high levels
initially would offer this virus a longer time-frame of replication
prior to debilitating antiviral responses of the host.
It has been estimated that only a small fraction of the inﬂuenza
virus mRNAs are spliced (10%) (Palese and Shaw, 2006), and that
inﬂuenza virus segment 7 and 8 mRNAs produced from cDNA expres-
sion plasmids are spliced with a different efﬁciency than mRNAs pro-
duced during infection (Lamb and Lai, 1980; Lamb and Lai, 1982;
Lamb et al., 1981). If that is a true estimate of the ratio of spliced to
unspliced, translationally competent inﬂuenza virusmRNAs in the cyto-
plasm in vivo in an infected individual, inefﬁcient splicing would have a
higher impact on the production of the proteins produced from spliced
mRNAs, the M2 and NS2 proteins, than on the expression levels of NS1
andM1.We show in this paper that the splicing efﬁciency of segment 7
and 8 mRNAs from different inﬂuenza viruses is different. This could
potentially affect virus replication and/or pathogenesis. The plausibility
that viruses with great differences in the splicing efﬁciency still would
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Fig. 9. (A) Schematic representations of pCMH1N1, pCMH3N2, and of the hybrids between segment 7 sequences from H1N1/Brevig Mission/1918/1 (Tumpey et al., 2005) and A/
Netherlands/178/95 (H3N2) (Rimmelzwaan et al., 2007). The names of the CMV-promoter-driven plasmids encoding the hybrids are indicated to the left. pCMH1N1 and pCMH3N2
encode the M protein coding region of A/Brevig Mission/1918/1 (H1N1) (Tumpey et al., 2005) and A/Netherlands/178/95 (H3N2) (Rimmelzwaan et al., 2007), respectively.
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which the 5′-splice site of segment 7 has been mutationally inactivated
failed to produce M2 protein, but replicated in vitro (Cheung et al.,
2005). M2 production is therefore not essential for virus replication in
cell culture, but the mutant viruses displayed an attenuated phenotype
(Cheung et al., 2005). NS2 is involved in the nuclear export of vRNAs
(O'Neil et al., 1998). Inﬂuenza virus replicationmay therefore be sensitive
to splicing efﬁciency of segment 8 mRNAs and the levels of NS2
expression (Wolschek et al., 2011). Although we have shown that
cis-acting RNA sequences determine the splicing efﬁciency of inﬂuenza
virus segment 7 and 8 mRNAs, it has been previously reported that theviral polymerase may act in trans to regulate splicing of the inﬂuenza
virus mRNAs (Shih et al., 1995). Therefore, splicing of inﬂuenza virus
segment 7 and 8 mRNAs are regulated by both cis-acting elements
and trans-acting factors. In addition, segment 7mRNAs encode a second
5′-splice site generating an mRNA named mRNA3 (Jackson and Lamb,
2008; Lamb and Lai, 1980; Lamb and Lai, 1982; Lamb et al., 1981; Shih
et al., 1995). However, mRNA3 does not appear to be required for
replication of inﬂuenza virus in vitro (Jackson and Lamb, 2008).
Theorigin of theA/BrevigMission/1918/1 (H1N1) virus is still debated
(Reid et al., 2004). The cloned and sequenced viruswas obtained from the
second wave of the pandemic in the autumn of 1918 and is therefore
55E. Backström Winquist et al. / Virology 422 (2012) 46–58believed to represent the more pathogenic virus that arose after the
summer in 1918 (Tumpey et al., 2005), as a result molecular changes
of the virus as it replicated in its human host. The sequence of the
less pathogenic 1918 virus of the ﬁrst wave is unknown, as is its true
origin. Our observation that segments 7 and 8 from A/Brevig Mission/
1918/1 (H1N1) are both inefﬁciently spliced suggests a common origin
of these two segments. It appears that segment 7 has properties that
suggest an avian origin (Reid et al., 2002), but with signs of adaptation
to a human host, whereas the origin of segment 8 has been more
difﬁcult to deduce (Basler et al., 2001). However, the splicing efﬁciency
of the two A/Brevig Mission/1918/1 (H1N1) derived segments was
equally inefﬁcient in avian QT6 cells as in human HeLa cells. In addition,
splicing of the A/Hong Kong/483/97 (H5N1) virus of avian origin (C,
Centers for disease control, prevention, 1997), although isolated from
a human patient, was equally efﬁcient in HeLa and QT6 cells. Inefﬁcient
splicing of both segment 7 and 8 mRNAs of inﬂuenza virus H1N1-1918,
and efﬁcient splicing of the corresponding H3N2-1995mRNAs, may re-
ﬂect an adaptation of each virus to different intracellular environments,
or may be purely coincidental. However, there are properties of avian
species that are not taken into account in these experiments, such as
the higher body temperature of birds and the replication of avian virus-
es in mucosal cells of the gut in their natural host (Kalthoff et al., 2010).
Poor splicing efﬁciency of the RNA segments derived fromA/Brevig
Mission/1918/1 (H1N1) is best described as the absence or presence of
RNA elements, or binding sites for cellular RNA-binding proteins that
regulate mRNA splicing (Blencowe, 2000; Cartegni et al., 2002). The
SR-protein- and the hnRNP-families represent well-known splicing
factors (Graveley, 2000; Long and Caceres, 2009; Shepard and Hertel,
2009; Taubenberger, 2006; Zhong et al., 2009). Although not studied
in great detail, it is established that the relative concentrations of
these factors differ between tissues (de la Grange et al., 2010; Grosso
et al., 2008)(www.proteinatlas.org), as well as between healthy and
diseased tissue (Fackenthal and Godley, 2008; Fay et al., 2009)
(www.proteinatlas.org). Autopsies of patients who succumbed to
the second wave of the Spanish ﬂu pandemic showed no signs of
systemic spread of the infection, or virus in any other tissue than
the airways. It is reasonable to speculate that various cells in the
upper or lower respiratory tract may display different SR-protein
or hnRNP-proﬁles, or other RNA-binding protein expression proﬁles.
Consequently, these cells would differ in their ability to accommodate
inﬂuenza viruses at the different compartments of the airways. High
levels of both ASF/SF2 and SRp55 are detected in the respiratory
epithelial cells in nasopharynx and bronchus, aswell as in pneumocytes
and macrophages in the lung (www.proteinatlas.org). In contrast,
SRp40 is undetectable in the pneumocytes and macrophages of the
lung, whereas high expression is observed in nasopharynx and
bronchus (www.proteinatlas.org). The only antiserum available to
SRp30c, to our knowledge, does not work in immunohistochemistry
and we have not seen stainings of airway epithelia for SRp30c
expression published. However, our ﬁndings reported here, show that
splicing of A/Brevig Mission/1918/1 (H1N1)- and A/Netherlands/178/
95 (H3N2)-mRNAs respond differently to ASF/SF2, SRp30c and SRp40
overexpression, and the observation that ASF/SF2 is highly expressed
in the lower respiratory tract, while SRp40 is not, indicates that the
interactions between viral RNA and cellular splicing factors may affect
replication of inﬂuenza viruses differently. More importantly, it may
determine where in the airways various inﬂuenza viruses would be
able to replicate.
A total of 37 nucleotide positions, relatively evenly distributed
between positions +250 and +690 (where A in the M ATG is
+1) in segment 7, differ between H1N1 and H3N2. One or more
of these changes are likely to affect binding sites for cellular splicing
factors. The analysis of potential binding sites for four different SR
proteins in the ESE ﬁnder program (Cartegni et al., 2003), did not
uncover consistent differences among the various inﬂuenza viruses,
although H3N2 segment 7 was predicted to contain fewer ASF/SF2 sitesthan H1N1. This was not the case for segment 8. We also subjected
radiolabelled segment 7 RNA from position 250 to 690 from A/Brevig
Mission/1918/1 (H1N1) inﬂuenza virus and A/Netherlands/178/95
(H3N2) to UV cross-linking to nuclear extract, but we did not identify
differences in proﬁles of proteins cross-linking to these RNAs (data
not shown). However, it should be said that UV-cross-linking is better
suited to detect differences in short RNA segments, and cross-linking
of these segment 7 RNAs of 440 nucleotides may therefore have failed
to detect differences in interactions with RNA binding proteins.
Furthermore, the structure of the inﬂuenza virus RNA may change
as a result of the sequence polymorphism (Gultyaev et al., 2007).
Such changes may also affect the functionality of the viral RNA.
The various inﬂuenza virus segment 7 and 8 expression plasmids
lack the UTR sequences and we cannot exclude that they affect
splicing efﬁciency as previously reported (Shih et al., 1995).
Materials and methods
Plasmids
To construct pCMHIN1, primers H1N1MS and H1N1MA were used
to PCR-amplify segment 7 coding sequences from A/Brevig Mission/1/
1918 (Reid et al., 2002; Tumpey et al., 2005). To construct pCMH3N2,
primers H3N2MS and H3N2MA were used to PCR-amplify segment 7
coding sequences from A/Netherlands/178/95 (Rimmelzwaan et al.,
2007). To construct pCMH5N1, primers H5N1MS and H5N1MA were
used to PCR-amplify segment 7 coding sequences from A/Hong
Kong/483/97. To construct pCNHIN1, primers H1N1NS and H1N1NA
were used to PCR-amplify segment 8 coding sequences from A/Brevig
Mission/1/1918 (H1N1) (Basler et al., 2001; Tumpey et al., 2005). To
construct pCNH3N2, primers H3N2NS and H3N2NA were used to
PCR-amplify segment 8 coding sequences from A/Netherlands/178/
95 (H3N2) (Rimmelzwaan et al., 2007). To construct pGs, primers
H5N1NS and H5N1NA were used to PCR-amplify segment 8 coding
sequences from A/Hong Kong/483/97 (H5N1) (C, Centers for disease
control, prevention, 1997). To construct pHn, primers H5N1NHnS
andH5N1NHnAwere used to PCR-amplify segment 8 coding sequences
of A/Hong Kong/483/97 (H5N1) (C, Centers for disease control,
prevention, 1997). The PCR-ampliﬁed sequences listed above were
separately digested with BssHII and XhoI and inserted into pCL0806
(Collier et al., 2002). To construct pGsGd, the coding region of A/
Goose/Guangdong/1/96 (H5N1) (Xu et al., 1999) was ﬁrst synthesised
in its entirety by GenScript, followed by digestion with BssHII and
XhoI and transfer to pCL0806 (Collier et al., 2002). The segment 7
H1N1-H3N2 hybrids were generated by PCR-mutagenesis using the
following primers for each plasmid: p1011 (H1N1MS, FMS1, FMA1
and H3N2MA), p1213 (H1N1MS, FMS2, FMA2 and H3N2MA), p1415
(H3N2MS, FMS3, FMA3 and H1N1MA), p1617 (H3N2MS, FMS4,
FMA4 and H1N1MA). The resulting PCR-fragments were digested
with BssHII and XhoI and transferred to plasmid pCL0806 (Collier et
al., 2002).
A Quick Change II PCR-mutagenesis kit (Stratagene) was used to
convert the NS ATG to TAA in pH3N2 and pH1N1, thereby creating
plasmids pH3N2dns and pH1N1dns, respectively. pNS1F-H5N1,
pNS1F-H1N1 and pNS1F-H3N2 were made by introducing mutations
at the 3′ splice site (splice acceptor), and mutations to destroy the
pyrimidine tract to avoid NS2 splicing using the Quick Change II
PCR mutagenesis method (Stratagene) with primers H1N1d3pSSrev
and H1N1d3pSSforw or H3N2d3pSSrev and H3N2d3pSSforw
(Table 1). The resulting plasmids were subjected to further PCR-
mutagenesis to insert a FLAG-tag at the C-terminus of NS1 using
primers CMVs in combination with either H1N1NS1Frev or
H3N2NS1Frev.
To construct pE5Luc, the HPV-16 E5 coding sequence, early UTR
and the early polyA signal pAE were PCR ampliﬁed with primers
Sense1 and E5AS and inserted into pBELM (Zhao et al., 2004) digested
Table 1
Oligonucleotides.
H1N1NS (5′-GGCGCGCACCatggattccaacactgtgtcaagcttt-3′)
H1N1NA (5′-CCTCGAGttaaataagctgaaacgagaaagttcttatc-3′)
H1N1MS (5′-GGCGCGCACCatgagtcttttaaccgaggtcgaaacg-3′)
H1N1MA (5′-CCTCGAGttactccagctctatgttgacaaaatgacc-3′)
H3N2NS (5′-GGCGCGCACCatggattccaacactgtgtcaagtttc-3′)
H3N2NA (5′-CCTCGAGttaaataagctgaaatgagaaagttcttatctc-3′)
H3N2MS (5′-GGCGCGCACCatgagccttctaacagaggtcgaaacg-3′)
H3N2MA (5′-CCTCGAGttactccagctctatgctgacaaaatgac-3′)
H5N1NGsS (5′-CCTCGAGttaaataagctgaaaagagaaggtccttatctc-3′)
H5N1NHnS (5′-GGCGCGCACCatggattccaacactgtgtcaagctttcagg-3′)
H5N1NHnA (5′-CCTCGAGttaaataagctgaaaagagaaggtccttatctc-3′)
H1N1d3pSSrev (5′-CCTCATCAGTATGTCCCGGTAGGCTTGGCAATGGACTAATTTCGCCAACAATTG-3′)
H1N1 d3pSSforw (5′-CAATTGTTGGCGAAATTAGTCCATTGCCAAGCCTACCGGGACATACTGATGAGG-3′)
H3N2d3pSSrev (5′-CCTCAATAGTATGTCCCGGGAAGCTTGGCAATGGACTGATTTCGCCAACAATTG-3′)
H3N2d3pSSforw (5′-CAATTGTTGGCGAAATCAGTCCATTGCCAAGCTTCCCGGGACATCATATTGAGG-3′)
H1N1NS1Frev (5′-ATATCTCGAGCTACTTGTCATCGTCGTCCTTGTAATCAACTTCTGACTTAATTGTTCTCGCC-3′)
H3N2NS1Frev (5′-ATATCTCGAGCTACTTGTCATCGTCGTCCTTGTAATCAACTTTTGACCTAGCTGTTCTCGCC-3′)
CMVs (5′-ccgtcagatcgcctggagacgcc-3′)
Sense 1 (5′-GGTCGACCCACCATGGACTACAAGGACGACGACGACAAGatgacaaatcttgatactgcatccacaacattactgg-3′)
E5AS (5′-GGGATCCcctgtttgcatgttttataaagttgggtagccgatgc-3′)
FMS1 (5′-cctagctccagtgctggtctgaaagATGATCTTCTTGAAAATTTGCAGAC-3′)
FMA1 (5′-GTCTGCAAATTTTCAAGAAGATCATctttcagaccagcactggagctagg-3′)
FMS2 (5′-cgtagacgctttgtccaaaatgcccTCAATGGGAATGGGGATCCAAATAA-3′)
FMA2 (5′-TTATTTGGATCCCCATTCCCATTGAgggcattttggacaaagcgtctacg-3′)
FMS3 (5′-CCTAGCTCCAGTACTGGTCTAAGAGacgatcttattgaaaatttgcaggc-3′)
FMA3 (5′-gcctgcaaattttcaataagatcgtCTCTTAGACCAGTACTGGAGCTAGG-3′)
FMS4 (5′-CGTAGACGCTTTGTCCAAAATGCCCttaatgggaacggggatccaaataa-3′)
FMA4 (5′-ttatttggatccccgttcccattaaGGGCATTTTGGACAAAGCGTCTACG-3′)
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ribosome entry site followed by the luciferase coding sequence was
inserted as a BamHI–XhoI fragment, resulting in pE5Luc.
Plasmids encoding inﬂuenza virus segment 7 and 8 sequences
were generously provided by the following researchers: Dr. R. Fouchier,
Erasmus Medical Center, The Netherlands, (A/Netherlands-178-95
(H3N2)) (Rimmelzwaan et al., 2007), Dr. A. Garcia-Sastre, Mount Sinai
School of Medicine, USA (A/Brevig Mission/1/1918 (H1N1)) (Tumpey
et al., 2005), Dr. Y. Kawaoka, University of Wisconsin-Madison, USA (A/
Hong Kong/483/97 (H5N1)) (C, Centers for disease control, prevention,
1997). The coding region of inﬂuenza virus A/Goose/Guangdong/1/96
(H5N1) (Xu et al., 1999) segment 8, from the NS ATG to the stop
codon of NS2, was synthesised by GenScript. RNA polymerase I-based,
recombinant A/WSN/33 (H1N1) inﬂuenza virus expression system
(Neumann and Kawaoka, 2001; Neumann et al., 2000) was generously
provided by Dr. Y. Kawaoka, University of Wisconsin-Madison.
Plasmids expressing ASF/SF2, SRp40, and SRp30c were kindly
provided by Dr. G. Akusjärvi, Uppsala University. SRp30cDRS have
been described previously (Somberg et al., 2011).Cells and transfections
293T cells were seeded in 60 mm plates in 4 ml DMEM containing
10% FCS, Penicillin (100 U/ml) and Streptomycin (100 μg/ml). The
cells were transfected with 1 μg plasmid DNA using TurboFect
(Fermentas) in 100 μl serum free DMEM according to the manufac-
turers protocol. Transfection of plasmid DNA into HeLa cells was
performed according to the Fugene 6 method (Roche Molecular
Biochemicals). When nothing else is stated, 1 μg of each plasmid was
transfected into 60 mm plates containing subconﬂuent HeLa cells.
Transfected HeLa or 293T cells were harvested 24 h post-transfection.
Avian ﬁbrosarcoma cell line QT6 (Lee et al., 2008; Moscovici et al.,
1977) from Japanese quail was obtained from ATCC. These cells were
seeded in 60 mm plates and transfected with TurboFect (Fermentas)
and harvested at 48 h posttransfection. All transfection experiments
shown in this manuscript were performed at least three times with
similar results.RNA extraction, Northern blotting and radiolabelled DNA probe synthesis
Isolation of total RNA was performed at 24 h posttransfection
using 1 ml TRI Reagent solution (Ambion) for each 60 mm plate
with cells, according to the manufacturers' protocol. Cytoplasmic
RNA was isolated after fractionation of transfected cells with isoB/
NP40 buffer (10 mM Tris pH 7.9, 0.15 M NaCl, 1.5 mM MgCl2, 0.5%
NP40), according to standard protocol. Nuclear RNA was isolated in
1 ml TRI Reagent solution (Ambion) from the nuclear pellet obtained
in the isoB/NP40 fractionation step. Oligo-dT beads (Ambion) were
used to extract polyadenylated cytoplasmic RNA according to the
manufacturers protocol.
Northern blotting was carried out by size separation of 10 μg cyto-
plasmic RNA on 1.2% agarose gels containing 2.2 M formaldehyde
followed by transfer over night to nitrocellulose ﬁlters. Filters were
hybridised to radiolabelled probe over night at room temperature.
DNA probes against CMV promoter derived sequences (CMV-pro-
moter driven plasmids) or NS coding sequences (RNA polymerase I
plasmids) were radiolabelled with [α-32P]dCTP using a Decaprime
kit (Ambion) or with Ready-to-lable beads (GE-Health Care). To
calculate percentage splicing, we divided the amount of radioactivity
(determined by phosphorimager Pharox (Biorad) using Quantity
One) in the band representing spliced mRNA with the sum of the
radioactivity in the bands representing spliced and unspliced
mRNA and multiplied with the factor 100.Reverse transcription (RT)-PCR
200 ng of cytoplasmic RNA was reverse transcribed at 42 °C using
Superscript II and random hexamers according to the manufacturers
protocol (Invitrogen). 2 μl of cDNA was ampliﬁed in a 100 μl reac-
tion with primers All_NS_FP (5′-GAATTCCAGCAAAAGCAGGGTGACA
AAGACATAATGGAT-3′) and All_NS-Rev (5′-AGTAGAAACAAGGGTGT
TTTTTATCATTAAAT-3′) that detect spliced and unspliced segment
8 mRNAs from various inﬂuenza virus types. GAPDH cDNA was am-
pliﬁed as control using previously described primers (Johansson
et al., 2005).
57E. Backström Winquist et al. / Virology 422 (2012) 46–58RNA polymerase I expression system
RNA polymerase I promoter driven plasmids encoding the entire
segment 8 of A/Brevig Mission/1/1918 (H1N1) (Tumpey et al., 2005)
or A/Netherlands/178/95 (Rimmelzwaan et al., 2007) were cotrans-
fectedwith four RNA polymerase II driven pCAGGS plasmids expressing
either A/WSN/33 inﬂuenza virus NP protein, PA, PB1 or pB2, as
described previously (Neumann and Kawaoka, 2001; Neumann et al.,
2000). Cytoplasmic, polyadenylated RNA was extracted at 24 h post-
transfection of 293T cells.
Luciferase assay
100 ng pE5Luc plasmid DNA, NS expressing plasmid as indicated
in the ﬁgure, and empty pCL0806 plasmid (Collier et al., 2002)
(empty vector) up to 500 ng or 1 μg were transfected in 35 mm
plates. Cells were collected and washed in 1 ml PBS and lysed in
200 μl lysis buffer (25 mM Tris pH 7.9, 2 mM DTT, 10% glycerol, 1%
Triton X-100). Luciferase activity was assayed on 40 μl cell lysate and
50 μl luciferin-assay solution (470 μM Beetle Luciferin-potassium salt
(Promega), 530 μM ATP, 270 μM coenzyme A, 33.3 mM DTT, 0.1 mM
EDTA, 2.67 mMMgSO4, 1.07 mM MgCO3, 20 mM Tricine pH 7.8).
Western blotting
Western blotting was performed according to the Odyssey proto-
col (Licor). In brief, cells were harvested in 250 μl RIPA (50 mM Tris
pH 7.4, 150 mM NaCl, 0.5% NP-40), 60 μg of protein lysate and protein
marker Biorad precision+ was separated on Any kD mini-PROTEAN
TGX precast gel at 300 V (Bio-RAD, 161–0377, 456–9033). Proteins
were transferred to Immobilon-FL membrane (Millipore, IPFL 00010).
The membrane was blocked in, and antibodies diluted in, Odyssey
blocking buffer:TBS (1:1) (Licor, 927–40000). ANTI-FLAG M2 diluted
1:5000 (Sigma), Anti-actin (I-19) diluted 1:5000 (Santa Cruz,
SC1616), IRDye antibodies diluted 1:20 000 (Licor, 926–32212,
926–32224). The membranes were scanned in Odyssey (Licor).
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